Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole in Male Libido Failure: Phase II Pilot Study
2009-010549-30Phase 2Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pramipexole in male sexual dysfunction (MSD), hypoactive sexual desire disorder (HSDD), erectile dysfunction (ED) and 2 more, sponsored by Policlinico Gemelli. Primary endpoints: Change in IIEF-15 score from baseline and Change in SF-36 score from baseline. Started Oct 2009; status: terminated.
02
Drugs
pramipexole
03
Conditions
male sexual dysfunction (MSD)hypoactive sexual desire disorder (HSDD)erectile dysfunction (ED)Delayed ejaculation (DE)anorgasmia
Beyond the preview
Go deeper on 2009-010549-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010549-30.